Insider Trading Stories
Disposition of 50000 shares by Wilson Jan C. of Horizon Kinetics subject to Rule 16b 3
few hours ago at MacroaxisInsider Filed By Wilson Jan C., Horizon Kinetics SPAC |
Filed transaction by Horizon Kinetics SPAC Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3. Horizon insider trading alert for disposition of class b common stock by Wilson Jan C., Director, on 17th of January 2025. This event was filed by Horizon Kinetics SPAC with SEC on 2022-03-16. Statement of changes in beneficial ownership - SEC Form 4 [Continue Reading...]
- SPAQ Horizon Kinetics SPAC
- SPAQ 98.57 0.17
- Low 98.57
- High 98.57
- Alpha 0.0254
- Beta 0.14
- Return On Equity 176.18
- Return On Asset -0.14
- Current Valuation 682.6 M
- Shares Outstanding 55.2 M
- Shares Owned By Institutions 88.82 %
- Number Of Shares Shorted 272.44 K
- Price To Earning 70.00 X
- Price To Book 138.89 X
- Net Income 6.62 M
- Cash And Equivalents 497.04 K
- Cash Per Share 0.01 X
- Current Ratio 0.22 X
- Book Value Per Share (0.76) X
- Cash Flow From Operations (2.03 M)
- Short Ratio 1.14 X
- Earnings Per Share 0.10 X
- Number Of Employees 5
- Beta 0.1
- Market Capitalization 445.74 M
- One Year Return 4.50 %
- Daily Balance Of Power 9.2 T
- Rate Of Daily Change 1.0
- Day Median Price 98.57
- Day Typical Price 98.57
- Price Action Indicator 0.085
- Period Momentum Indicator 0.17
Filed transaction by LUCKY STRIKE ENTERTAINMENT Director, Officer: Executive Vice Chairman. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e). Disposition of 4079120 stock option (right to buy) at 7.92 of LUCKY STRIKE by Parker Brett I. on 13th of January 2025. This event was filed by LUCKY STRIKE ENTERTAINMENT with SEC on 2025-01-13. Statement of changes in beneficial ownership - SEC Form 4 |
39 minutes ago at Macroaxis Filed for Parker Brett I. |
Filed transaction by LIONS GATE ENTERTAINMENT Director, Officer: Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e). LIONS insider trading alert for disposition of class b common shares by Feltheimer Jon, Director, Officer: Chief Executive Officer, on 31st of December 2024. This event was filed by LIONS GATE ENTERTAINMENT with SEC on 2024-12-31. Statement of changes in beneficial ownership - SEC Form 4 |
46 minutes ago at Macroaxis Filed for Feltheimer Jon |
Filed transaction by Horizon Kinetics SPAC Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3. Horizon insider trading alert for disposition of class b common stock by Wilson Jan C., Director, on 17th of January 2025. This event was filed by Horizon Kinetics SPAC with SEC on 2022-03-16. Statement of changes in beneficial ownership - SEC Form 4 |
few hours ago at Macroaxis Filed for Wilson Jan C. |
Filed transaction by Customers Bancorp Officer: Cfo Customers Bank. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e). Disposition of 20000 stock options (right to buy) at 28.37 of Customers Bancorp by Watkins Philip on 17th of January 2025. This event was filed by Customers Bancorp with SEC on 2026-02-24. Initial filing of beneficial ownership - SEC Form 3 |
few hours ago at Macroaxis Filed for Watkins Philip |
Filed transaction by Hawthorn Bancshares Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3. Disposition of 1817 common stock at 32.21 of Hawthorn Bancshares by Holtaway Jonathan on 17th of January 2025. This event was filed by Hawthorn Bancshares with SEC on 2024-12-04. Statement of changes in beneficial ownership - SEC Form 4 |
few hours ago at Macroaxis Filed for Holtaway Jonathan |
Disposition of 9975 shares by Fordyce Marshall of Vera Therapeutics at 41.5335 subject to Rule 16b 3
Filed transaction by Vera Therapeutics Director, Officer: President And Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e). Disposition of 9975 class a common stock at 41.5335 of Vera Therapeutics by Fordyce Marshall on 8th of January 2025. This event was filed by Vera Therapeutics with SEC on 2025-01-08. Statement of changes in beneficial ownership - SEC Form 4 |
few hours ago at Macroaxis Filed for Fordyce Marshall |
Filed transaction by Alaunos Therapeutics Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e). Disposition of 818 common stock at 2.0 of Alaunos Therapeutics by Vieser Jaime on 31st of December 2024. This event was filed by Alaunos Therapeutics with SEC on 2024-12-31. Statement of changes in beneficial ownership - SEC Form 4 |
few hours ago at Macroaxis Filed for Vieser Jaime |
Filed transaction by PEDEVCO Corp Officer: Chief Commercial Officer. Insider Public Trading. PEDEVCO insider trading alert for general transaction of common stock by Crook Jody D., Officer: Chief Commercial Officer, on 1st of January 2025. This event was filed by PEDEVCO Corp with SEC on 2025-01-01. Initial filing of beneficial ownership - SEC Form 3 |
few hours ago at Macroaxis Filed for Crook Jody D. |
Filed transaction by Regulus Therapeutics Officer: Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e). Disposition of 5088 common stock at 1.2632 of Regulus Therapeutics by Calsada Crispina on 14th of January 2025. This event was filed by Regulus Therapeutics with SEC on 2025-01-14. Statement of changes in beneficial ownership - SEC Form 4 |
few hours ago at Macroaxis Filed for Calsada Crispina |